N2-[(2R)-4-[(1,1-Dimethylethoxy)amino]-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl]sulfonyl]amino]iminoethyl-L-ornithine

CAS: 1093740-20-5

Ref. TR-D472945

Informação sobre produto

• Nome: N2-[(2R)-4-[(1,1-Dimethylethoxy)amino]-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-N5-[[[2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl]sulfonyl]amino]iminoethyl-L-ornithine
• Sinónimos: N2-((R)-4-(tert-butoxyamino)-2-(naphthalen-2-ylmethyl)-4-oxobutanoyl)-Nw-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)-L-arginine
• Marca: TRC
• Descrição: Applications Intermediate in the synthesis of substrate-selective peptide hydroxamate inhibitor of insulin-degrading enzyme, N2-[(2R)-4-(Hydroxyamino)-2-(2-naphthalenylmethyl)-1,4-dioxobutyl]-L-arginyl-L-tryptophyl-L-α-glutamine (H828110).References Abdul-Hay, S.O., et al.: J. Med. Chem., 56, 2246 (2013)

Propriedades químicas

• Peso molecular: 737.91
• Fórmula: C₃₈H₅₁N₅O₈S
• Cor/forma: Neat
• InChI: InChI=1S/C38H51N5O8S/c1-22-23(2)33(24(3)29-21-38(7,8)50-32(22)29)52(48,49)43-36(39)40-17-11-14-30(35(46)47)41-34(45)28(20-31(44)42-51-37(4,5)6)19-25-15-16-26-12-9-10-13-27(26)18-25/h9-10,12-13,15-16,18,28,30H,11,14,17,19-21H2,1-8H3,(H,41,45)(H,42,44)(H,46,47)(H3,39,40,43)/t28-,30+/m1/s1